Summary
The present work evaluates the performances of a Bayesian program (PKS) for phenytoin concentration predictions in an outpatient population. The retrospective study involved 19 epileptic adults receiving oral phenytoin. The program was used to predict estimated serum concentrations from 0, 1, 2 or 3 feedback concentrations. Measurements of prediction bias (ME) decreased as soon as one steady-state concentration (Css) was used for estimations. Precision (MAE) was significantly improved with 1 Css and was even better and stable with 2 and 3 Css. Likewise, RMSE (composite of bias and precision) regularly decreased when the number of Css used increased. On a clinical way, 12% of the estimations were unacceptable (prediction error > 5 mg/l) with 1 Css and less than 3% with 2 or 3 Css. This number of rejected estimations increased to 45% when no feedback concentration was used. Besides, the program was able to predict important rises of serum levels in spite of relative low increase of the dose when 1 Css at least was known. Thus, the phenytoin dosing program has acceptable performances when at least 1 Css is known, and represents a potential tool to assist the clinician in the particular condition of outpatient population.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Richens A., Dunlop A. (1975): Serum phenytoin levels in management of epilepsy, Lancet, 2, 247–248
Mullen P.W. (1978): Optimal phenytoin therapy: a new technique for individualizing dosage, Clin. Pharmacol. Ther., 23, 228–232
Graves N.M., Leppik I.E., Termond E., Taylor J.W. (1986): Phenytoin clearances a compliant population: description and application, Ther. Drug Monit., 8, 427–433
Vozeh S., Muir K.T., Sheineer L.B., Follath F. (1981): Predicting individual phenytoin dosage, J. Pharmacokinet. Biopharm., 9, 131–146
Grasela T.H., Sheiner L.B., Rambeck B. et al. (1983), Steady-state pharmacokinetics of phenytoin from routinely collected patient data, Clin. Pharmacokinet., 8, 355–364
Yuen G.J., Latimer P.T., Littlefield L.C., Mackey R.W. (1989): Phenytoin dosage predictions in paediatric patients, Clin. Pharmacokinet., 16, 254–260
Leppik I.C., Cloyd J.C., Sawchuk R.I., Pepin S.M. (1979): Compliance and variability of plasma phenytoin levels in epileptic patients, Ther. Drug. Monit., 1, 475–483
Sheiner L.B., Beal S.L., Rosenberg B., Marathe V.V. (1979): Forecasting individual pharmacokinetics, Clin. Pharmacol. Ther., 26, 294–305
Beal S.L. (1983): Computation of the explicit solution to the Michaelis-Menten equation, J. Pharmacokinet. Biopharm., 11, 641–657
Ludden T.M., Beal S.L., Peck C.C., Godley P.J. (1986): Evaluation of a Bayesian regression-analysis program for predicting phenytoin concentration, Clin. Pharmacol., 5, 580–585
Crowley J.J., Koup J.R., Cusack B.J., Ludden T.M., Vestal R.E. (1987): Evaluation of a proposed method for phenytoin maintenance dose prediction following an intravenous loading dose, J. Clin. Pharmacol., 32, 141–148
Privitera M.D., Homan R.W., Ludden T.M., Peck C.C., Vasko M.R. (1989): Clinical utility of a Bayesian dosing program for phenytoin, Ther. Drug Monit., 11, 285–294
Jusko W.J., Koup J.R., Gunnar A. (1976): Nonlinear assessment of phenytoin bioavailability, J. Pharmacokinet. Biopharm., 4, 327–336
Tozer T.N., Winter M.E. (1980): Phenytoin In Evans W. E. et al. eds Applied pharmacokinetic principles of therapeutic drug monitoring, Applied Therapeutics, San Francisco, pp. 275–314
Garcia M.J., Gavira R., Santos Buelga D., Dominguez-Gil A. (1994): Predictive performance of two phenytoin pharmacokinetic dosing programs from non steady-state data, Ther. Drug Monit., 16, 380–387
Welty T.E., Robinson F.C., Mayer P.R. (1986): A comparison of phenytoin dosing methods in private practice seizure patients, Epilepsia, 27, 76–80
Sheiner L.B., Beal S.L. (1981): Some suggestions for measuring predictive performance, J. Pharmacokinet. Biopharm., 9, 503–512
Bryson S.M., Al-Lanqawi Y., Kelman A.W., Whiting B. (1988): Comparison of a Bayesian forecasting technique with a new method for estimating phenytoin dose requirements, Ther. Drug Monit., 10, 80–84
Vazquez A., Santos Buelga D., Alonso A.C., Garcia M.J., Dominguez-Gil A. (1991): Comparison of methods for the prediction of phenytoin concentrations, J. Clin. Pharmacol. Ther., 16, 55–62
Yuen G.J., Taylor J.W., Ludden T.M., Murphy M.J. (1983): Predicting phenytoin dosages using Bayesian feedback: a comparison with other methods, Ther. Drug Monit., 5, 437–441
Yukawa E., Higuchi S., Aoyama T. (1989): Clinical evaluation of population pharmacokinetic parameters in phenytoin dosage adjustment, Chem. Pharm. Bull., 37, 3363–3366
Botha J.H., Miller R., Moodley M. (1991): Estimating phenytoin dosages in black African and Indian children, Clin. Pharm., 10, 928–931
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gaulier, J.M., Boulieu, R., Fischer, C. et al. Evaluation of a bayesian pharmacokinetic program for phenytoin concentration predictions in outpatient population. European Journal of Drug Metabolism and Pharmacokinetics 23, 295–300 (1998). https://doi.org/10.1007/BF03189354
Issue Date:
DOI: https://doi.org/10.1007/BF03189354